As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Amgen: Oak Hill Wealth Advisors LLC, Simplex Trading LLC, IMC Chicago LLC, Readystate Asset Management LP, Parallax Volatility Advisers L.P., Berkley W R Corp, BlueCrest Capital Management Ltd, Cubist Systematic Strategies LLC, Verition Fund Management LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Eisler Capital US LLC, Eisler Capital UK Ltd., Kopernik Global Investors LLC, Bank of Nova Scotia, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, Mendel Money Management, IMC Chicago LLC, One River Asset Management LLC, Wells Fargo & Company MN, UBS Group AG, BNP Paribas Financial Markets, Gladius Capital Management LP, Concourse Financial Group Securities Inc., Genus Capital Management Inc., Private Advisor Group LLC, Savant Capital LLC, XR Securities LLC, Wolverine Asset Management LLC, and SpiderRock Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.